The Who
English rock band
The Who ▸ Facts ▸ Comments ▸ News ▸ Videos
The Who are an English rock band formed in London in 1964. Their classic lineup (1964–1978) consisted of lead vocalist Roger Daltrey, guitarist Pete Townshend, bassist John Entwistle and drummer Keith Moon. They are considered one of the most influential rock bands of the 20th century. Their contributions to rock music include the development of the Marshall stack, large public address systems, the use of synthesisers, Entwistle's and Moon's influential playing styles, Townshend's feedback and power chord guitar technique, and the development of the rock opera. They are cited as an influence by many hard rock, punk, power pop and mod bands. The Who were inducted into the Rock and Roll Hall of Fame in 1990.
| 0 shares | ShareTweetSavePostSend |
You Might Like
India reports 395 new Covid cases, two deaths in 24 hoursIndia records 395 New COVID-19 cases and 2 deaths in 24 Hours; Omicron Variant (JN.1) raises concerns. The country's active caseload stands at 3,075, with a total death toll of 5,33,414. The Omicron..IndiaTimes - Published | |
619 cases of Covid sub-variant JN.1 reported from 12 states till January 4The number of COVID-19 cases of the JN.1 sub-variant reported from 12 states rose to 619 as of January 4. The majority of those infected are opting for home-based treatment, indicating mild illness...IndiaTimes - Published | |
Terminologies used for traditional medicine to be on WHO list soonThe WHO will include traditional medicine terminologies in its International Classification of Diseases (ICD) list, releasing the classifications in Delhi next week. The ICD classification of..IndiaTimes - Published | |
No need to panic over Covid surge, but mask up, say doctorsNearly 7 months after the WHO withdrew the public health emergency notification for Covid-19, the virus refuses to go away. The Omicron variant has mutated into several new subvariants, with the..IndiaTimes - Published | |
Cases of Covid JN.1 sub-variant detected in India: Symptoms, precautions & other FAQsThe JN.1 variant of Covid, causing concern in India, has mild to moderate symptoms such as fever, runny nose, sore throat, headaches, loss of appetite, and extreme fatigue. Gastrointestinal problems..IndiaTimes - Published | |
Is India ready for China's H9N2 health crisis? Here's what Centre saysThe WHO's overall risk assessment suggests a low probability of human-to-human spread and a low case fatality rate among reported H9N2 cases.DNA - Published | |
Niti Aayog's VK Paul urges for more quality healthcare from private sectorDr VK Paul, a member of NITI Aayog, has called for increased support from the private sector to deliver quality healthcare in India. He emphasized the government's commitment to strengthening the..IndiaTimes - Published | |
No EG.5 threat in India, says Mandaviya as new Omicron variant causes surge in Covid-19 incus, UKMandaviya said the government continues to aggressively pursue genomic surveillance to detect Covid-19 clusters and new variants, if any, even though the cases of the viral infection have reduced...IndiaTimes - Published | |
Tobacco: Farmers' body writes to PMO, finance ministry against WHO recommendationFarmer organisation Federation of All India Farmer Associations (FAIFA) has written to the Prime Minister's Office (PMO) and finance ministry against the WHO recommendation that alternative crops..IndiaTimes - Published | |
With raids and show-cause notice, govt plans mega crackdown on cough syrup maker under WHO lens over Gambia deathsThe WHO warned that four cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths of 66 children in The Gambia.DNA - Published | |
WHO alert on 4 Indian cough syrups as 66 Gambian kids dieThe WHO on Wednesday issued a medical product alert on four ‘cough & cold’ syrups made by an Indian pharmaceutical firm — Maiden Pharmaceuticals Ltd, Sonipat, Haryana — warning they could be..IndiaTimes - Published | |
Breaking: First case of new Omicron sub-variant XE detected in IndiaA warning was issued by the WHO last week regarding the new Omicron sub-variant XE, which was first discovered in the UK in March.DNA - Published | |
Cannot cut corners, need to thoroughly evaluate product before recommending emergency use: WHO on CovaxinThe WHO on Monday said it cannot cut corners and needs to thoroughly evaluate a product before recommending it for EUL to ensure it is safe and effective. “We are aware that many people are waiting..IndiaTimes - Published | |
